Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

Mariangela Massaccesi; Milena Ferro; Savino Cilla; Mario Balducci; Francesco Deodato; Gabriella Macchia; Vincenzo Valentini; Alessio Giuseppe Morganti

doi:10.1007/s10147-012-0462-0

Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

Mariangela Massaccesi
, Milena Ferro
, Savino Cilla
, Mario Balducci
, Francesco Deodato
, Gabriella Macchia
, Vincenzo Valentini
, Alessio Giuseppe Morganti

Risultato della ricerca: Contributo in rivista › Articolo

12 Citazioni (Scopus)

Abstract

We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme.

Lingua originale	Inglese
pagine (da-a)	784-791
Numero di pagine	8
Rivista	International Journal of Clinical Oncology
Volume	18
DOI	https://doi.org/10.1007/s10147-012-0462-0
Stato di pubblicazione	Pubblicato - 2013

Keywords

radiotherapy

Accesso al documento

10.1007/s10147-012-0462-0

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{7f86ae08aa8f4edc87f81987127f6093,

title = "Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)",

abstract = "We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme.",

keywords = "radiotherapy, radiotherapy",

author = "Mariangela Massaccesi and Milena Ferro and Savino Cilla and Mario Balducci and Francesco Deodato and Gabriella Macchia and Vincenzo Valentini and Morganti, \{Alessio Giuseppe\}",

year = "2013",

doi = "10.1007/s10147-012-0462-0",

language = "English",

volume = "18",

pages = "784--791",

journal = "International Journal of Clinical Oncology",

issn = "1341-9625",

publisher = "Springer",

}

TY - JOUR

T1 - Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

AU - Massaccesi, Mariangela

AU - Ferro, Milena

AU - Cilla, Savino

AU - Balducci, Mario

AU - Deodato, Francesco

AU - Macchia, Gabriella

AU - Valentini, Vincenzo

AU - Morganti, Alessio Giuseppe

PY - 2013

Y1 - 2013

N2 - We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme.

AB - We performed a dose-escalation trial to determine the maximum tolerated dose (MTD) of intensity-modulated radiotherapy (IMRT) with standard concurrent and sequential-dose temozolomide (TMZ) in patients with glioblastoma multiforme.

KW - radiotherapy

UR - http://hdl.handle.net/10807/52299

U2 - 10.1007/s10147-012-0462-0

DO - 10.1007/s10147-012-0462-0

M3 - Article

SN - 1341-9625

VL - 18

SP - 784

EP - 791

JO - International Journal of Clinical Oncology

JF - International Journal of Clinical Oncology

ER -

Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1)

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo